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Abstract. 
 
Red blood cell protein 4.1 (4.1R) is an 80-
kD erythrocyte phosphoprotein that stabilizes the spec-
trin/actin cytoskeleton. In nonerythroid cells, multiple 
4.1R isoforms arise from a single gene by alternative 
splicing and predominantly code for a 135-kD isoform. 
This isoform contains a 209 amino acid extension at its 
 
NH
 
2
 
 terminus (head piece; HP). Immunoreactive 
epitopes speciﬁc for HP have been detected within the 
cell nucleus, nuclear matrix, centrosomes, and parts of 
the mitotic apparatus in dividing cells. Using a yeast 
two-hybrid system, in vitro binding assays, coimmu-
nolocalization, and coimmunoprecipitation studies, we 
show that a 135-kD 4.1R isoform speciﬁcally interacts 
with the nuclear mitotic apparatus (NuMA) protein. 
NuMA and 4.1R partially colocalize in the interphase 
nucleus of MDCK cells and redistribute to the spindle 
poles early in mitosis. Protein 4.1R associates with 
NuMA in the interphase nucleus and forms a complex 
with spindle pole organizing proteins, NuMA, dynein, 
and dynactin during cell division. Overexpression of a 
135-kD isoform of 4.1R alters the normal distribution 
of NuMA in the interphase nucleus. The minimal se-
quence sufﬁcient for this interaction has been mapped 
to the amino acids encoded by exons 20 and 21 of 4.1R 
and residues 1788–1810 of NuMA. Our results not only 
suggest that 4.1R could, possibly, play an important role 
in organizing the nuclear architecture, mitotic spindle, 
and spindle poles, but also could deﬁne a novel role for 
its 22–24-kD domain.
 
Key words: protein 4.1R • NuMA • dynein • dynactin • 
mitotic spindle
 
R
 
ED
 
 blood cell protein 4.1 (4.1R)
 
1
 
 was identified as an
80-kD cytoskeletal protein in red cells (Ungewic-
kell et al., 1979). It is critical for the organization
and maintenance of the spectrin/actin cytoskeleton, and
for the attachment of the cytoskeleton to the cell mem-
brane through interactions with integral membrane pro-
teins such as glycophorin C, and Band 3 (Tyler et al., 1979;
Anderson et al., 1984; Pasternack et al., 1984). Abnormali-
ties in 4.1R are associated with congenital red cell defects
leading to membrane fragmentation and hereditary ellip-
tocytosis. It is well established that the 80-kD 4.1R of ma-
ture red cells is only one member of a large family of 4.1R
isoforms that arise from a single gene by alternative
mRNA splicing (Tang et al., 1990; Conboy et al., 1991), us-
age of at least two translation initiation sites (Huang et al.,
1992; Chasis et al., 1996), and posttranslational modifica-
tions (Subrahmanyam et al., 1991). Recently three new
4.1-like genes have been identified that share strong ho-
mology with the 30-, 10-, and 22–24-kD domains of 4.1R.
One of them is generally expressed throughout the body
(4.1G; Parra et al., 1998), another one is expressed in cen-
tral and peripheral neurons (4.1N; Walensky, L.D., S.
Blackshaw, J.G. Conboy, N. Mohandas, and S.H. Snyder.
1997. 
 
Soc. Neurosci
 
. 23:1674a), and a third one is ex-
pressed in brain (4.1B; Parra, M., P. Gascard, L.D. Walen-
sky, S.H. Snyder, N. Mohandas, and J.G. Conboy. 1997.
 
Mol. Biol. Cell.
 
 [Suppl.] 8:177a).
The major functions of erythrocyte 4.1R have been well
described. The 30-kD NH
 
2
 
-terminal domain of erythro-
cyte 4.1R interacts with glycophorin C, calmodulin, p55
(Tanaka et al., 1991; Hemming et al., 1994; Marfatia et al.,
1995), and band 3 (Jons and Drenckhahn, 1992). The 10-kD
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Abbreviations used in this paper:
 
 Ab, polyclonal antibody; 4.1R, red
blood cell protein 4.1; Gal4-AD, Gal4 activation domain; Gal4-BD, Gal4
DNA-binding domain; HP, head piece or the NH
 
2
 
-terminal extension of
4.1R; IP, immunoprecipitation buffer; NuMA, nuclear mitotic apparatus
protein. 
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domain contains binding sites for spectrin and actin com-
plexes (Correas et al., 1986; Discher et al., 1993; Horne et al.,
1993). Purified 4.1R also interacts specifically with tubulin
(Correas and Avila, 1988) and myosin (Pasternack and
Racusen, 1989).
Isoforms of 4.1R are widely expressed in many tissues
and are phylogenetically conserved. They are heteroge-
neous with regard to molecular mass, abundance, and cel-
lular localization (Cohen et al., 1982; Granger and Laza-
rides, 1984, 1985; Anderson et al., 1988). Western blots of
many types of mammalian and avian cells revealed 4.1R
immunoreactive epitopes in protein species ranging from
30 to 210 kD (Granger and Lazarides, 1984; Anderson et
al., 1988) in nucleated erythroid and nonerythroid cells. In
contrast to the strict peripheral localization of 4.1R in ma-
ture red cells, 4.1R isoforms in nucleated cells are concen-
trated at points of cell–cell or cell–matrix contact, along
stress fibers, on cytoplasmic matrixlike structures (Cohen
et al., 1982; Lue et al., 1994), and perinuclear regions such
as centrosomal and Golgi structures (Leto et al., 1986;
Chasis et al., 1993). Several groups have also documented
the presence of 4.1R isoforms in centrioles and the nucleus
(Madri et al., 1988; De Carcer et al., 1995; Krauss et al.,
1997a,b). 4.1R isoforms have also been observed as a com-
ponent of the nuclear matrix of mammalian cells (De
Carcer et al., 1995; Krauss et al., 1997b). Transcription-
dependent redistribution of nuclear 4.1R to SC35-enriched
nuclear domains suggests that 4.1R, in the nucleus, may be
involved in splicing processes (Lallena and Correas, 1997).
Also isoforms of 4.1R in the nucleus have been postulated
to be significant contributors to nuclear architecture and
serve as structural elements (Krauss et al., 1997b). 
Our earlier observation (Marchesi, V.T., S. Huang, T.K.
Tang, and E.J. Benz, Jr. 1990. 
 
Blood.
 
 76:12a) and those of
Krauss et al. (1997b) showed that 4.1R is located in the nu-
cleus during interphase and it rapidly redistributes to the
developing spindle poles when the nuclear envelope dis-
sembles in prometaphase, a characteristic of nuclear ma-
trix proteins that leave the nucleus during interphase/
mitosis transition to become structural components of the
mitotic apparatus, seen both in mammalian cells (for re-
view see He et al., 1995) and 
 
Drosophila
 
 (Saunders et al.,
1997). The multiplicity of 4.1R isoforms combined with
the diversity of possible protein–protein interactions sug-
gests that individual 4.1R isoforms may have specific and
discrete functions. However, little is known about the cy-
tochemistry, biochemical functions, or physiologic impor-
tance of 4.1R isoforms other than in red cells.
To understand the function of 4.1R isoform(s) in non-
erythroid cells, we searched for proteins that interact with
the 135-kD 4.1R. This isoform arises from alternative
mRNA splicing resulting in the addition of 209 amino ac-
ids to the NH
 
2
 
-terminal end of erythrocyte 4.1R (HP;
Tang et al., 1990). We performed a yeast two-hybrid
screen of a human brain cDNA library using 135-kD iso-
form of 4.1R as a bait and isolated several clones encoding
the COOH-terminal domain of nuclear mitotic apparatus
(NuMA) protein, a protein known to augment organiza-
tion and stabilization of the mitotic spindle. NuMA was
suggested to stabilize the parallel arrays of microtubules
that emerge from the centrosomes early in mitosis (Yang
and Snyder, 1992). During the transition from mitosis to
 
interphase, NuMA may have a role in stabilizing the teth-
ering of chromosomes to each spindle pole and/or provide
structural support to the nucleus during the complex reas-
sembly process (Kallajoki et al., 1991; Compton and Cleve-
land, 1993).
We report here that a 135-kD 4.1R isoform associates
with NuMA in vivo and partially colocalizes at different
stages of the cell cycle. This isoform also associates with
NuMA, cytoplasmic dynein, and dynactin during cell divi-
sion. Furthermore, its overexpression leads to alteration in
the intracellular localization of NuMA in interphase. The
later proteins are involved in tethering the microtubules at
the spindle poles and are essential for mitotic spindle pole
stabilization. Therefore, our results imply strongly that a
nonerythroid 4.1R isoform may have a role in cell division.
 
Materials and Methods
 
Antibody Production
 
Antiserum to synthetic peptides of segments of 10 kD (MESVPEPRPS-
EWDK), 22–24 kD (GVLLTAQTITSETPSSTTTTKITKC, exon 19) do-
main, or to the recombinant HP of 4.1R (anti-HP 4.1) was produced. Anti-
synthetic peptide antibodies were prepared and purified as described
earlier (Leto et al., 1986). The DNA fragment containing the coding se-
quence for the 209 amino acids of HP of 4.1R was fused in frame to GST
by using pGEX-2T vector, expressed in 
 
Escherichia coli
 
, and purified on
glutathione-Sepharose 4B beads according to the manufacturer’s recom-
mendations (Pharmacia Biotech Inc.). Aliquots of GST-HP 4.1 fusion
protein were mixed with complete Freund’s adjuvant and injected subcu-
taneously into New Zealand White male rabbits. 4 wk later the rabbits
were given a booster dose of incomplete adjuvant. Sera were collected by
bleeding through ear vein and were cleared by centrifugation. The sera
were purified on immunoaffinity columns using resins covalently cross-
linked to the fusion peptide used for immunization. The purified antibod-
ies were eluted from the columns with 0.1 N acetic acid, neutralized, and
dialyzed against 0.1 M borate buffer, pH 8.0.
Anti-NuMA antibodies (raised in rabbit) used in this study were previ-
ously characterized (Yang and Snyder, 1992). In some experiments, an
anti-NuMA mAb (Oncogene) was also used. The anti–Na
 
1
 
-K
 
1
 
-ATPase
 
a
 
1 polyclonal antibody (Ab) used was described previously (Zahler et al.,
1993). Antidynein mAb (intermediate chain, clone 70.1), anti-actin mAb,
antispectrin (
 
a
 
 and 
 
b
 
) mAb, and anti–
 
g
 
-tubulin Ab were purchased from
Sigma Chemical Co. Anti-p150
 
glued
 
 mAb (the largest subunit of dynactin)
was purchased from Transduction Laboratories. Antipericentrin Ab and
anticalmodulin mAb were purchased from BAbCO and Zymed Laborato-
ries, Inc., respectively.
 
Plasmid Construction
 
cDNAs were generated by restriction digestion of 4.1R cDNAs (Tang
et al., 1988) or by PCR using an amplification kit (Promega Corp.) and a
thermocycler (PCR System 480; Perkin-Elmer Corp.). For the full-length
(135-kD) 4.1R construct, the SmaI and BglII fragment from pTM-Full was
subcloned into the SmaI and BamHI site of pAS2-1. For subcloning the
80-kD 4.1R or its different domains, DNA sequences were PCR amplified
from 135 kD/PTM-Full or 80 kD/pEry-1,2,3 (Tang et al., 1988) using cus-
tom oligonucleotide primers (Genosys Biotechnologies) designed with
SalI and PstI sites at their 5
 
9
 
 or 3
 
9
 
 ends, respectively. The primers designed
for generation of 4.1R domains (see Fig. 1 A and GenBank/EMBL/DDBJ
under accession number J03796) were as follows: Hp/pAS2-1 (47–69/651–
673), 30 kD/pAS2-1 (674–696/1539–1461), 16 kD/pAS2-1 (1462–1484/
1762–1784), 10 kD/pAS2-1 (1785–1807/1900–1922), and 22–24 kD/pAS2-1
(1923–1942/2354–2374). The amplified cDNAs were digested with SalI
and PstI, purified, and cloned into SalI and PstI sites of Gal4 DNA-bind-
ing domain vectors, pGBT9 or pAS2-1, by standard methods.
Different NuMA constructs containing the NuMA cDNA correspond-
ing to NH
 
2
 
-terminal domain (308–878), coiled-coil domain (877–5335), or
COOH-terminal domain (5356–6720) were cloned in frame with Gal4
transactivation domain in vector pACTII. The 135-kD/GST fusion con-
struct was generated by subcloning the EcoRI and SalI insert of 135 kD/
pAS2-1 into EcoRI and SalI sites of pGEX-6P1 (Pharmacia Biotech Inc.). 
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For 80 kD/GST and its different domains in GST vector pGEX-6P1, cus-
tom primer sets with the same sequences used for Gal4 DNA-binding do-
main (Gal4-BD) constructs, except with EcoRI or SalI at their 5
 
9
 
 or 3
 
9
 
ends, were used to amplify the corresponding cDNA sequences, digested
with EcoRI and SalI, and were subcloned in frame into pGEX-6P1. The
135
 
11
 
kD/GFP construct was generated by cloning a human 4.1R cDNA
containing all exons (Baklouti et al., 1997) except exons 3, 14, 15, 17a/a
 
9
 
and 17b in frame into KpnI and BamHI sites of pEGFP-C1 (CLONTECH
Laboratories). NuMA/TOPO constructs containing sequences corre-
sponding to 5356–6561 (NuMA1/TOPO), 5356–5929 (NuMA2/TOPO), or
5752–6561 (NuMA3/TOPO) of NuMA (available from GenBank/EMBL/
DDBJ under accession number Z11584) were amplified with addition of
the Kozak consensus sequence and the translation initiation site (GC-
CACCATG) incorporated into the 5
 
9
 
 end and a stop codon at the 3
 
9
 
 end.
The amplified fragments were cloned into pCR
 
®
 
-Blunt II-TOPO vector
(Invitrogen Corp.). To ensure correctness of the reading frame, the 5
 
9
 
-
junction of each construct was sequenced using a sequencing kit (seque-
nase v. 2.0; Amersham Corp.).
Deletion constructs representing different exons of the 22–24-kD do-
main of 4.1R were derived from 22–24 kD/pAS2-1 by using custom oligo-
nucleotide primers as above, and were cloned into SalI and PstI sites of
pGBT9. The primers (see Fig. 3 A and GenBank/EMBL/DDBJ under
accession number J03796) used were as follows: exons 17–21/pGBT9
(1923–1942/2354–2374), exon 18–21/pGBT9 (1963–1981/2354–2374), exon
18–20/pGBT9 (1963–1981/2275–2295), exon 18–19/pGBT9 (1963–1981/
2175–2194), exon 19/pGBT9 (2093–2112/2175–2194), exon 20/pGBT9
(2195–2217/2275–2295), exon 21 (2276–2298/2354–2374), and exon 20–21
(2195–2217/2354–2374). The construct exon 19–21/pGBT9 was made by a
two-step PCR using the primer set (2093–2112/2164–2194 and 2276–2285)
and (2185–2194 and 2276–2296/2354–2374) for the first round of amplifi-
cation. The primary PCR products were annealed and the second round
of PCR was done with the 5
 
9
 
and 3
 
9
 
 primers (2093–2112/2354–2374). The
constructs exon 21 (amino acids 762–775)/pGBT9 and exon 21 (amino ac-
ids 745–761)/pAS2-1 were derived from 22–24 kD/pAS2-1 by using the
SmaI and StyI sites, respectively. Different deletion constructs of NuMA
were derived from NuMA 1476–2115/pACT2 or NuMA 1697–2115/
pACT2 (see Fig. 1 B and GenBank/EMBL/DDBJ under accession num-
ber Z11584). The plasmids were digested with BglII, the fragment of in-
terest was purified, digested with the available restriction enzyme at the 3
 
9
 
site of interest, and blunt-ended. Afterwards, the cDNA fragments were
digested with EcoRI, purified, and cloned into pACT2 at the EcoRI and
blunt-ended XhoI sites. The NuMA 1788–1832/pACT2 construct was de-
rived from NuMA 1697–2115/pACT2 using custom oligonucleotide prim-
ers (5621–5647 and 5736–5758, these data are available from GenBank/
EMBL/DDBJ under accession number Z11584) designed with EcoRI and
XhoI site at their 5
 
9
 
 or 3
 
9
 
 ends, respectively, as above. The authenticity of
all deletions was confirmed by dideoxy sequencing in both directions.
 
Yeast Two-Hybrid Assay
 
The Gal4-based MATCHMAKER two-hybrid system II of CLONTECH
Laboratories, Inc. was followed for the yeast two-hybrid assays. Plasmid
vectors, pAS2-1 or pGBT9, and pACT2, encoding the Gal4-BD and Gal4-
activating domain (Gal4-AD), respectively, were used to express hybrid
proteins. To screen for proteins that interact with 4.1R in yeast two-hybrid
system, a human brain cDNA library in Gal4-AD vector pACT2 was
screened using either the full-length 4.1R (135-kD) or the 22–24 kD of
4.1R cloned into Gal4-BD vector (see plasmid construction section for de-
tails) as the bait. Positive clones were tested further for specificity by
cotransformation into Y190 either with 4.1R 135 kD/pAS2-1, 22–24 kD/
pAS2-1, or with pAS2-1 alone. DNA from positive clones were isolated,
the Gal4-AD plasmids were recovered in bacteria strain HB 101, and se-
quenced by dideoxy method as above. For domain mapping, plasmids car-
rying respective inserts fused to Gal4-BD or Gal4-AD were cotrans-
formed into yeast, and were assayed for 
 
b
 
-galactosidase activity on
nitrocellulose filters as described in CLONTECH Laboratories’ manual.
 
In Vitro Binding Assay
 
The in vitro transcription/translation of NuMA/TOPO was performed us-
ing the TNT
 
®
 
 coupled (reticulocyte lysate system; Promega Corp.) in the
presence of [
 
35
 
S]methionine to radiolabel newly synthesized proteins.
Equal amounts of the labeled NuMA proteins were incubated with affin-
ity-purified GST/4.1R fusion proteins coupled to glutathione-Sepharose
beads for 1 h at 4
 
8
 
C in binding buffer (50 mM potassium phosphate, pH
7.3, 150 mM NaCl, 2.7 mM KCl, 4 
 
m
 
g/ml aprotinin, 4 
 
m
 
g/ml leupeptin, 4
 
m
 
g/ml antipain, 12.5 
 
m
 
g/ml chymostatin, 12 
 
m
 
g/ml pepstatin, 130 
 
m
 
g/ml
 
e
 
-amino caproic acid, 200 
 
m
 
g/ml 
 
p
 
-NH
 
2
 
-benzamidine, and 1 mM PMSF).
After incubation, the immobilized NuMA-4.1R complex was washed five
times with binding buffer in the presence of 1% Triton X-100, once with
the binding buffer plus 1% Triton X-100, 2 M urea and 100 mM glycine,
and once with the binding buffer. The bound protein complex was sub-
jected to analysis on a 15% or 18% SDS-PAGE, treated with Enlightning
(NEN Life Science), and visualized by fluorography.
 
Cell Culture, Transfection, and Synchronization
 
HeLa (ATCC CCL 2, human cervix epitheloid carcinoma) and MDCK
(ATCC CRL 1772, Madin-Darby canine kidney) cells were grown in
DME supplemented with 10% heat-inactivated FBS (GIBCO BRL). The
cDNA encoding the full-length 4.1R (80 kD 4.1R [Baklouti et al., 1997]
containing HP without exon 3) in pEGFP-C1 vector (135
 
11
 
kD/GFP) or
the vector pEGFP-C1 was transiently transfected into HeLa cells using Li-
pofectAmine reagent following the manufacturer’s procedure (GIBCO
BRL). The 135
 
11
 
kD/GFP cDNA contained all of the known 4.1R exons
except exon 3 and the tissue-specific exons 14, 15, 17a/a
 
9
 
, and 17b. Cells in
a 100-mm
 
2
 
 dish were transfected for 16 h, the GFP- or 135
 
11
 
kD/GFP–
transfected cells were sorted using a FACStar
 
®
 
 cell sorter to avoid the un-
transfected cell population overgrowth, and the transfected cells were col-
lected. The sorted cells were plated on poly-
 
D
 
-lysine–coated coverslips
and the samples were taken daily for 5 d, fixed, and processed for immu-
nofluorescence staining. The transfected cells were immunofluorescence-
stained using Texas red–conjugated anti–mouse IgG, anti-NuMA mAb,
and TO-PRO-3 (for DNA staining), and were examined for the presence
of 135
 
11
 
kD/GFP fusion protein, Texas red, and Cy 5 fluorescence in indi-
vidual cells.
Highly enriched mitotic HeLa cells were prepared by synchronization
of the cells at G1/S boundary of the cell cycle by double thymidine block
(O’Conner and Jackman, 1995). Cells were grown in complete medium
for 4 h and the mitotic population was enriched by addition of 0.25 
 
m
 
g/ml
of nocodazole for 6 h. Afterwards, cells were washed twice with complete
medium, allowed to grow for 90 min in complete medium, and were col-
lected by mitotic shake-off.
 
Subcellular Fractionation and Western Blotting
 
Expression of 4.1R and NuMA at protein level in MDCK cells was docu-
mented by Western blotting. Cytoplasmic-, nuclear-, and nuclear matrix-
protein fractions were prepared as described (Mattagajasingh and Misra,
1996). The protein contents were determined using a protein determina-
tion kit (Pierce Chemical Co.). 20 
 
m
 
g of protein from each fraction was an-
alyzed on 8–12% SDS-polyacrylamide gels (National Diagnostics Inc.).
NuMA and 4.1R were detected by Western blotting using 1:500 dilution of
anti-HP 4.1 or anti-NuMA antibodies as described earlier (Mattagajasingh
and Misra, 1996) except that HRP conjugated goat anti–rabbit IgG and an
ECL detection kit (Amersham Corp.) were used.
 
Coimmunoprecipitation and Immunoblotting
 
Coimmunoprecipitation of 4.1R and NuMA was performed using MDCK
nuclear extracts. Nuclei were purified as described (Mattagajasingh and
Misra, 1996), resuspended in coimmunoprecipitation (IP) buffer (25 mM
Tris-HCl, 100 mM NaCl, 1 mg/ml BSA, 0.2 mM EDTA, 5 mM iodoacet-
amide, 0.05%[wt/vol] SDS, 4 
 
m
 
g/ml aprotinin, 4 
 
m
 
g/ml leupeptin, 4 
 
m
 
g/ml
antipain, 12.5 
 
m
 
g/ml chymostatin, 12 
 
m
 
g/ml pepstatin, 130 
 
m
 
g/ml 
 
e
 
-amino
caproic acid, 200 
 
m
 
g/ml 
 
p
 
-amino-benzamidine, and 1 mM PMSF, pH 7.5),
and given 20 strokes in a tight-fitting glass homogenizer. The nuclear ho-
mogenate was centrifuged at 10,000 
 
g
 
 for 10 min at 4
 
8
 
C, and the superna-
tant was used for coimmunoprecipitation. Preimmune serum (rabbit)
equivalent to 30 
 
m
 
g IgG was added to 1 mg of nuclear proteins and incu-
bated for 2 h at 4
 
8
 
C, followed by the addition of 200 
 
m
 
l of a 50% suspen-
sion of protein A–Sepharose 6 MB (Pharmacia) in IP buffer for 2 h at 4
 
8
 
C.
The supernatant was collected by centrifugation at 5,000 
 
g
 
 for 5 min at 4
 
8
 
C
and equally split into five tubes. Preimmune serum, affinity-purified anti-
HP 4.1 Ab, anti-NuMA mAb, mouse IgG, or anti-p53 mAb containing 4 
 
m
 
g
IgG were added to different tubes and incubated for 2 h at 4
 
8
 
C. Protein
A–Sepharose 6 MB (100 
 
m
 
l of a 50% suspension) was added and incu-
bated as above.
For immunoprecipitation using mitotic HeLa extracts, cells were ho-
mogenized as above in IP buffer containing 170 mM NaCl, 2% Nonidet
P-40, 0.1% (wt/vol) SDS, and 5 mM iodoacetamide. After centrifugation
at 10,000 
 
g
 
 for 10 min at 4
 
8
 
C, the supernatant was used for immunoprecip- 
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itation using 4 
 
m
 
g each of anti-NuMA mAb, anti-HP 4.1 Ab, antidynein
mAb, anti-p150
 
glued
 
 mAb, anti-p53 mAb (an irrelevant antibody), mouse
IgG or preimmune serum (rabbit), as above. After incubation with pro-
tein A–Sepharose, the samples were centrifuged for five min at 5,000 
 
g
 
 at
4
 
8
 
C, and washed 5–10 times in 900 
 
m
 
l of IP buffer containing 1% Nonidet
P-40 and 5 mM iodoacetamide. The samples were resuspended in 60 
 
m
 
l of
SDS sample buffer (62.5 mM Tris-HCl, 10% glycerol, 2% [wt/vol] SDS,
5% 2-mercaptoethanol, and 10 
 
m
 
g/ml bromophenol blue, pH 6.8) and
heated at 98
 
8
 
C for 5 min. The samples were centrifuged at 10,000 
 
g
 
 for 10
min at 4
 
8
 
C and the supernatants were fractionated on 7–10% SDS-poly-
acrylamide gels. Transfer of proteins to nitrocellulose membrane and im-
munodetection of 4.1R or NuMA were carried out as described above.
Some chemiluminograms were scanned using the Adobe Photoshop soft-
ware (Adobe Systems, Inc.) and the protein bands of interest were quanti-
tated by using the NIH Image software for the Apple Macintosh com-
puter. In some cases, the gels were stained with the GelCode
 
®
 
 Blue
Reagent or the GelCode
 
®
 
 SilverSNAP™ (Pierce Chemical Co.).
 
Fluorescence and Confocal Microscopy
 
MDCK or HeLa cells were grown on poly-
 
D
 
-lysine–coated glass cover-
slips. Coverslips were washed twice with PBS and immersed in a microtu-
bule stabilizing buffer (4 M glycerol, 100 mM Pipes, pH 6.9, 1 mM EGTA,
and 5 mM MgCl
 
2
 
) for 2 min at room temperature and fixed in 2%
paraformaldehyde, 0.4% glutaraldehyde, 90 mM Pipes, pH 6.8, 1 mM
EGTA, and 5 mM MgCl
 
2
 
 for 5 min at room temperature. Cells were
washed three times with TBS (10 mM Tris-HCl, pH 7.5, 150 mM NaCl,
1% albumin) and permeabilized with TBS containing 0.5% Triton X-100
for 5 min. Subsequently, the cells were washed three times with TBS con-
taining 10 mM glycine. Cells were blocked with TBS containing 10% nor-
mal goat serum for 30 min at room temperature.
For single staining, cells were either incubated with anti-HP 4.1 anti-
body (diluted 1:50) or anti-NuMA antibody (diluted 1:100) in TBS for 1 h
at room temperature. Cells were washed in 10 mM glycine/TBS and incu-
bated with goat anti–rabbit IgG conjugated to FITC (for anti-HP 4.1) or
donkey anti–rabbit IgG conjugated to Texas red (for NuMA) for 1 h at
room temperature followed by four washes in 10 mM glycine/TBS. When
double staining was desired, after the first set of staining, cells were
blocked with TBS containing 10
 
 m
 
g/ml goat anti–rabbit Fab fragment fol-
lowed by four washes in 10 mM glycine/TBS to reduce the nonspecific rec-
ognition by the second set of antibodies. Incubation with the second set of
antibodies was the same as the first set of antibodies. Finally, the cover-
slips were mounted in mounting buffer (100 mM 
 
n
 
-propyl gallate, 50%
glycerol in PBS, pH 7.4) and the samples were viewed with a Nikon micro-
phot-FXA or with a laser scanning confocal system (MRC 600; Bio-Rad
Laboratories) coupled to a Zeiss Axiophot microscope through a 60
 
3 
 
oil
immersion objective. Images were processed using Photoshop software
(Adobe Systems, Inc.) and photographed from the monitor screen.
 
Results
 
4.1R and NuMA Interact in the Yeast
Two-Hybrid Assays
 
To understand the function of a predominant noneryth-
roid 4.1R isoform (135 kD), we detected its binding part-
ners by using a yeast two-hybrid system. Using the fusion
protein Gal4-BD/135 kD 4.1R (Fig. 1. A) as a bait in
pAS2-1 and a human brain cDNA library fused to Gal4-
AD in pACT2, we screened 
 
z
 
8 
 
3
 
 10
 
6
 
 transformants. 79
positive clones were obtained, out of which 35 clones con-
tained sequences that when translated would correspond
to either amino acid residues 1476–2115 or 1697–2115 of
NuMA (Fig. 1 B; these data are available from GenBank/
EMBL/DDBJ under the accession number Z11584). When
Gal4-BD/22–24 kD 4.1R was used as a bait (Fig. 1 A),
some of the positive clones obtained also corresponded to
the residues 1697–2115 of NuMA (these data are available
from GenBank/EMBL/DDBJ under accession number
Z11584). This interaction of 4.1R and NuMA in the two-
hybrid assays seemed to be specific, because neither the
Gal4-BD 4.1R hybrid interacted with the unfused Gal4-
AD, nor did the Gal4-AD–NuMA hybrid (clones obtained
from the library screening) interact with the unfused Gal4-
BD (data not shown).
Three NuMA isoforms of 230, 195, and 194 kD have
been reported. These isoforms arise by alternative splicing
from a common precursor of a single NuMA gene but dif-
fer at their COOH termini (Tang et al., 1994). The NuMA
protein has three different domains (Maekawa and Ku-
riyama, 1993). The NH
 
2
 
- and COOH-terminal’s globular
domains correspond to residues 1–207 and 1729–2115, re-
spectively. The middle 
 
a
 
-helical coiled-coil domain com-
prises residues 208–1728. The positive clones obtained in
the two-hybrid assays corresponded to the COOH-termi-
nal end of the coiled-coil domain and the COOH-terminal
globular domain. This could have derived from the 230-kD
NuMA isoform because a part of these sequences was not
detected in 195-kD and 194-kD isoforms of NuMA. In the
230-kD NuMA isoform, residues 1972–2007 were shown
to contain a nuclear localization signal; the residues 1538–
2115 are necessary and sufficient for its spindle associa-
tion. This isoform of NuMA is present in interphase nuclei
and has been shown to concentrate at the polar regions of
the spindle apparatus in mitotic cells (Tang et al., 1994).
 
Protein 4.1R and NuMA Interact through their
COOH-terminal Domains
 
To identify the domains of 4.1R and NuMA responsible
for their interaction, we expressed different domains of
Figure 1. Schematic representation of 4.1R and
NuMA peptides found to interact in the yeast
two-hybrid screening of a human brain cDNA li-
brary. (A) The organization of protein 4.1R and
its 22–24-kD domain peptides employed as bait in
the yeast two-hybrid assays. Different exons of
4.1R gene that correspond to its different do-
mains are shown. The asterisks represent the al-
ternatively spliced exons. (B) A schematic repre-
sentation of the structural organization of the
NuMA protein and its segments encompassed by
positive clones obtained as prey in the two-hybrid
assays. 
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4.1R as fusion products of Gal4-BD in pAS2-1 and
cotransformed into Y190 with different domains of NuMA
expressed as Gal4-AD fusion products in pACTII or
pACT2, as shown in Fig. 2. The full-length (135-kD) 4.1R,
its 80-kD isoform, and the 22–24-kD domain interacted
with the COOH-terminal domain, but not the NH
 
2
 
-termi-
nal or the coiled-coil domain of NuMA, in the yeast two-
hybrid assays. The HP, 30-, 16-, or 10-kD domain of 4.1R
did not interact with NuMA. None of the domains of 4.1R,
when expressed as Gal4-BD fusion proteins in Y190, ex-
pressed the reporter genes by themselves or in combina-
tion with the Gal4-AD in pACT2 alone (data not shown).
These data suggest that the COOH-terminal domains of
4.1R and NuMA are necessary and sufficient for their in-
teraction.
 
Interaction between 4.1R and NuMA Occurs through 
the COOH-terminal 62 Amino Acids of 4.1R and Amino 
Acids 1788–1810 of NuMA
 
To delineate the minimal sequences of 4.1R and NuMA
that interact, we examined the interactions between differ-
ent segments of the COOH-terminal domains of both the
4.1R and NuMA in the yeast two-hybrid assays, by ex-
pressing segments of the COOH-terminal domain of 4.1R
as Gal4-BD fusion proteins and that of NuMA as Gal4-
AD fusion proteins, respectively. Neither the deletion of
the amino acids encoded by the part of exon 17 that be-
longs to the 22–24-kD domain of 4.1R (exons 18–21/
pGBT9), nor the deletion of the amino acid residues en-
coded by exons 17, 18, and 19 (exons 20 and 21/pGBT9)
affected the interaction between 4.1R and NuMA. Dele-
tion of the peptide segment encoded by exon 21 (exons
18–20/pGBT9) abolished the interaction of 4.1R with
NuMA, although this segment alone (exon 21/pGBT9)
was not sufficient for binding to NuMA (Fig. 3 A). The
amino acids encoded by exons 20 and 21 of 4.1R (exons 20
and 21/pGBT9) were sufficient for its association with
NuMA. However, the amino acids encoded by exon 20
alone (exon 20/pGBT9) did not bind to NuMA. There-
fore, the extreme COOH-terminal 62 amino acids of 4.1R
derived from exons 20 and 21 are required and sufficient
for its interaction with NuMA.
 
The two different clones of NuMA obtained from the
yeast two-hybrid screening started at positions corre-
sponding to amino acids 1476 and 1697 of NuMA. Peptide
segments of NuMA representing amino acids 1476–1695
or 1697–1787 did not interact with 4.1R (Fig. 3 B). Dele-
tion of NuMA sequences representing the amino acids
from the COOH-terminal end to 1804 resulted in a weak
interaction with 4.1R, whereas amino acids 1788–1810
showed substantial binding. Therefore, we believe that
amino acids 1788–1810 of NuMA are necessary and suffi-
cient for its interaction with 4.1R. These results suggest
that the interaction between 4.1R and NuMA occurs
through the amino acids encoded by exons 20 and 21 of
4.1R, and the amino acids 1788–1810 of NuMA.
 
Protein 4.1R Interacts with NuMA In Vitro
 
To confirm the direct interaction between 4.1R and NuMA,
the association was further analyzed by an in vitro binding
assay. GST-tagged 135-, 80-kD, and different domains
(HP, 30, 16, 10, and 22–24 kD) of 4.1R were expressed and
purified (Fig. 4 A). Because of the insolubility of the 30-
kD peptide, there was minor host protein contamination
in preparations of 30 kD/GST and 80 kD/GST fusion pro-
teins (lanes 2 and 8, respectively). In 16 kD/GST prepara-
tion, another protein band, probably a degradation prod-
uct, was also observed (lane 3). The authenticity of these
fusion proteins was verified with the corresponding anti-
bodies (data not shown). Immobilized GST-tagged 4.1R
proteins were incubated with in vitro translated and
[
 
35
 
S]methionine-labeled NuMA peptides corresponding
to amino acids 1697–2102 (NuMA1/TOPO), 1697–1889
(NuMA2/TOPO), or 1831–2102 (NuMA3/TOPO). Reten-
tion of NuMA peptides on the beads was analyzed by
SDS-PAGE as described in Materials and Methods. The
yeast two-hybrid assays showed that NuMA sequences re-
quired for its interaction with 4.1R are located within
amino acid sequences 1788–1810. As shown in Fig. 4, B
and C, both NuMA1/TOPO and NuMA2/TOPO that con-
tained these sequences bound strongly to both 135-kD and
80-kD 4.1R isoforms and its 22–24-kD domain. The HP,
30-, 16-, and 10-kD domains, or GST alone did not bind to
NuMA. NuMA3/TOPO, which did not contain these se-
Figure 2. 4.1R and NuMA inter-
act through their COOH-termi-
nal domains. 4.1R and NuMA
peptides and their segments
were expressed as Gal4-BD or
Gal4-AD fusion proteins, re-
spectively, in yeast strain Y190
by cotransformation, and were
assayed for the expression of the
reporter genes (see Materials
and Methods). (1) indicates the
expression of the reporter
genes, LacZ and HIS3 (and thus
the interaction between the pep-
tides) and (2) indicates nonex-
pression of the reporter genes
(and thus no interaction be-
tween the peptides). 
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quences, did not bind to any of the 4.1R/GST fusion pro-
teins (Fig. 4 D). These results are consistent with that of
the yeast two-hybrid assays, and further confirm the spe-
cific interaction between 4.1R and NuMA.
 
Expression and Subcellular Localization of 4.1R and 
NuMA in HeLa and MDCK Cells
 
We verified the expression of 4.1R and NuMA in HeLa
and MDCK cells, both at the RNA and protein level. A
6.5-kb 4.1R mRNA and a 7.2-kb NuMA mRNA were de-
tected in HeLa and MDCK cells (data not shown). Affin-
ity-purified antibodies specific for HP (anti-HP 4.1) recog-
nized four different protein bands in cytoplasmic protein
fraction (molecular masses of z35, 45, 76, and 135 kD),
two bands in the nuclear protein fraction (35 and 135 kD),
and a major 135-kD band in the nuclear matrix fraction of
MDCK cells (Fig. 5 B). However, no protein band was
seen when a replica blot was immunoblotted with the pre-
immune serum (Fig. 5 A). 
To verify that the protein bands recognized by anti-HP
4.1 Ab are also recognized by other anti-4.1R antibodies,
replica blots were also immunoblotted with antibodies
specific for exon 19 (Fig. 5 C, anti-24 kD Ab) and the 10-kD
domain of 4.1R (Fig. 5 D, anti-10 kD Ab). In addition to
other bands, both the anti-24 kD Ab and anti-10 kD Ab
recognized a predominant 135-kD protein band in cyto-
plasmic, nuclear, and nuclear matrix fractions, suggesting
that the 135-kD protein band recognized by the anti-HP
4.1 Ab is 4.1R. Unexpectedly, the anti-24 kD Ab did not
show an 80-kD band in any of the fractions. This could
have resulted from a low level of expression of 80 kD iso-
form(s) containing exon 19 in these cells. The anti-10 kD
Ab revealed the presence of both the 135- and 80-kD 4.1R
isoforms in the cytoplasmic and nuclear fractions, and ad-
ditionally detected the presence of 4.1R epitopes in a pre-
dominant z110 kD polypeptide that was localized both in
the cytoplasmic and nuclear fractions (Fig. 5 D). Similar
distribution of 4.1R was observed in MDCK cells using
anti-HP 4.1 antibodies and immunofluorescent staining
(data not shown). The 135-kD isoform of 4.1R was pre-
dominantly localized in the nucleus, centrosomes, and to
some extent at the points of cell–cell contact of interphase
cells. Also, it was localized in the mitotic spindle and spin-
dle poles of dividing cells. These results are consistent with
recent studies that 4.1R epitopes are localized in cen-
trosomes, nucleus, and nuclear matrix (Krauss et al.,
1997a,b).
The anti-NuMA antibodies recognized two immunore-
active bands of z210 and 230 kD in the nuclear and nu-
Figure 3. Interaction between 4.1R and NuMA
occurs through the COOH-terminal 62 amino
acids of 4.1R and amino acids 1788–1810 of
NuMA. (A) Schematic diagrams of the various
exons within the 22–24-kD domain of 4.1 (white
rectangles) fused to the DNA binding domain of
GAL4 (shaded rectangles) used in the two-
hybrid assay are shown. The names of the plas-
mids that encoded each construct are given to
the right of each schematic diagram. Plasmid
pAS2-1 expresses the GAL4-BD alone and was
used as a negative control. These plasmids were
cotransformed with pACT2-NuMA expressing
amino acids 1697–2115 of NuMA fused to the ac-
tivation domain of Gal4. The column on the
right shows the results of filter assays for b-galac-
tosidase (b-gal) activity as the reporter gene: (1)
indicates the expression of the reporter genes
(and thus the interaction between the peptides)
and (2) indicates nonexpression of the reporter
genes (and thus no interaction between the pep-
tides). The last 62 amino acids of protein 4.1 en-
coded by exons 20 and 21 bind to NuMA. (B)
Schematic diagrams of the various NuMA
polypeptides (dotted rectangles) fused to the ac-
tivation domain of GAL4 (shaded rectangles)
used in the two-hybrid assay are shown. Plasmid
pACT2, which expresses the Gal4-AD alone,
was used as a negative control. These plasmids
were cotransformed with pGBT9 or pAS2-1 ex-
pressing COOH-terminal domain of 4.1R or its
exons 20 and 21 fused to the DNA-binding do-
main of GAL4. The column on the right shows
the results of filter assays for b-galactosidase ac-
tivity: (11) indicates strong b-gal activity, (1)
indicates detectable b-gal activity, and (2) indi-
cates no detectable b-gal activity.Mattagajasingh et al. Protein 4.1R Interacts with NuMA 35
clear matrix protein fractions, and a 210-kD band in the
cytoplasmic fraction (Fig. 5 E). This is consistent with the
observation that two different isoforms of NuMA are ex-
pressed in interphase cells (Zeng et al., 1994). Previously
published results (Yang and Snyder, 1992) suggest that
NuMA is localized in the nucleus of interphase cells. We
believe that the minor fraction of NuMA seen in the cyto-
plasmic fraction (Fig. 5 E) occurred because of some cell
nuclei lysis during cell fractionation.
To assess the quality of subcellular fractionation and
document that the 4.1R isoform(s) seen in the nuclear and
nuclear matrix fractions are not due to contamination of
cytoplasmic proteins, different subcellular fractions were
also immunoblotted with antibodies to proteins known to
localize in cell cytoplasm (Pfarr et al., 1990; Zahler et al.,
1993). Immunoblotting with anti–Na1-K1-ATPase a1 Ab
(Fig. 5 F) and antidynein mAb (Fig. 5 G) detected an
z120- and 70-kD band, respectively, only in the cytoplas-
mic fraction. This suggests that the 4.1R isoform(s) seen in
the nuclear and nuclear matrix fractions is not the result of
contamination of 4.1R isoforms localized in the cytoplasm.
Because 4.1R isoforms are documented to associate
with centrosomes at mitosis and even after microtubule
depolymerization (Krauss et al., 1997a; Krauss, S.W., R.
Heald, G. Lee, T. Berger, and J.A. Chasis. 1998. Mol. Biol.
Cell. [Suppl.] 9:294a), different subcellular fractions were
immunoblotted with antibodies for centrosomal markers
such as g-tubulin (Stearns and Kirschner, 1994) and peri-
centrin (Doxsey et al., 1994). This was done to abrogate
the possibility that 4.1R isoforms seen in nuclear and nu-
clear matrix fractions could have occurred because of cen-
trosomal contamination in these fractions. Immunoblot-
ting of different subcellular fractions with anti–g-tubulin
Ab (Fig. 5 H) and antipericentrin Ab (Fig. 5 I) showed the
corresponding 48-kD g-tubulin and 220-kD pericentrin
only in cytoplasmic fraction. This suggests undetectable
centrosomal contamination in the nuclear and nuclear ma-
trix fractions.
4.1R and NuMA Colocalize at Different Stages of the 
Cell Cycle
To further localize the association of 4.1R and NuMA, we
used double immunofluorescence staining and confocal
microscopy, and analyzed MDCK cells at different stages
of cell cycle (see Materials and Methods). In interphase,
4.1R epitopes were found diffusely in the cytoplasm,
but predominantly inside the nucleus (Fig. 6 A1, green),
whereas NuMA epitopes were found mainly inside the nu-
clei (Fig. 6 A2, red). In mitotic cells, both 4.1R and NuMA
intensely stained the spindle poles as shown in B1/C1 and
B2/C2, respectively. NuMA epitopes were mainly found in
the nucleus of the newly forming daughter cells (D2),
whereas 4.1R epitopes were seen in the cytoplasm as well
as nuclei (D1). The yellow color produced by superimpos-
ing green and red suggested that some 4.1R and NuMA
epitopes colocalized in interphase nuclei (A3), in the mi-
totic spindle and spindle poles (B3 and C3), and in the
daughter cell nuclei (D3). Krauss et al. (1997b), using im-
munogold staining and electron microscopy, observed that
in the interphase 4.1R epitopes were primarily found in
the vicinity of dense bodies. Zeng et al. (1994) reported
that NuMA was present in subsets of the core filaments.
However, using double label immunofluorescent staining
and confocal microscopy, Krauss et al. (1997b) also ob-
served 4.1R foci within the nuclear area that was stained
by NuMA. These results, the diffuse distribution of 4.1R
during interphase and its segregation at the spindle poles
during mitosis, are similar to those of other proteins es-
sential for mitotic spindle assembly such as, NuMA (Price
and Pettijohn, 1986), dynein (Steur et al., 1990), HSET
(Kuriyama et al., 1995), and Eg5 (Houliston et al., 1994).
Protein 4.1R and NuMA Associate In Vivo
To determine whether the native 4.1R interacts with
NuMA in vivo, coimmunoprecipitation assays were per-
formed using nuclear extracts from MDCK cells. MDCK
nuclear extracts were subjected to coimmunoprecipitation
with anti-HP 4.1 or anti-NuMA antibodies. Coprecipitated
polypeptides were detected by immunoblot staining using
anti-HP 4.1 or anti-NuMA antibodies. As shown in Fig. 7,
A and B, when preimmune serum, mouse IgG, or anti-p53
mAb were used to immunoprecipitate MDCK nuclear ex-
Figure 4. Protein 4.1R interacts with NuMA in vitro. Purified
bacterially produced 4.1R/GST fusion proteins were incubated
with [35S]methionine-labeled NuMA. After incubation, the
bound protein complexes were analyzed by SDS-PAGE and vi-
sualized by fluorography. (A) Purified 4.1R/GST fusion proteins
are shown by Coomassie blue staining: HP/GST (lane 1); 30
kD/GST (lane 2); 16 kD/GST (lane 3); 10 kD/GST (lane 4); 24
kD/GST (lane 5); GST (lane 6); 135 kD/GST (lane 7); and 80 kD/
GST (lane 8). (B) Binding of 4.1R/GST to [35S]methionine-labeled
NuMA amino acid sequence 1697–2102 translated from NuMA1/
TOPO is shown. (C) Binding of 4.1R/GST to NuMA amino acid
sequence 1697–1889 translated from NuMA2/TOPO. (D) Bind-
ing of 4.1R/GST to NuMA amino acid sequence 1831–2102 trans-
lated from NuMA3/TOPO. The input [35S]methionine-labeled
NuMA proteins are shown on the far left lane.The Journal of Cell Biology, Volume 145, 1999 36
tracts, neither 4.1R (Fig. 7 A, lanes 2, 4, and 5) nor NuMA
(Fig. 7 B, lanes 2, 4, and 5) precipitated. However immu-
noprecipitation with anti-HP 4.1 Ab and subsequent de-
tection with anti-NuMA mAb showed that anti-HP 4.1 Ab
precipitates two proteins of z210 and 230 kD (Fig. 7 B,
lane 1). These proteins comigrate with two polypeptides of
similar molecular mass that were immunoprecipitated by
anti-NuMA mAb (Fig. 7 B, lane 3) and were detected by
immunoblotting using anti-NuMA antibodies. Similarly,
immunoprecipitation with anti-NuMA mAb precipitated a
protein of z135 kD (Fig. 7 A, lane 3) that comigrates with
4.1R and immunoreacts with anti-HP 4.1 Ab (Fig. 7 A,
lane 1).
These results suggest that a nuclear isoform of 4.1R and
NuMA is contained in the same protein complex in vivo.
The coprecipitation of NuMA by anti-HP 4.1 antibodies,
detection of 4.1R that coprecipitated with NuMA by anti-
HP 4.1 antibodies, and the molecular mass of 4.1R isoform
that coprecipitates with NuMA (135 kD) suggest that the
4.1R isoform(s) that interact(s) with NuMA is a 135-kD
isoform that contains HP observed in nonerythroid iso-
forms. To find out which fractions of 4.1R and NuMA as-
sociate together, the efficiencies of immunoprecipitation
and coprecipitation were determined. Quantitation from
Fig. 7, A and B, shows that z29% of 4.1R was precipitated
by anti-HP 4.1 Ab (that coprecipitated z8% NuMA) and
z47% of NuMA was precipitated by anti-NuMA mAb
which in turn brought down z15% 4.1R. The limited effi-
ciency of the immunoprecipitation could have happened
because of insufficient amounts of antibodies in the immu-
noprecipitation assays. The lower efficiency of coimmuno-
precipitation as compared with that of the immunoprecipi-
tation suggests that only a fraction of these molecules
associate together in vivo. This is consistent with the sub-
cellular fractionation and immunofluorescent staining re-
sults.
To examine the possible interaction of other isoforms
of 4.1R with NuMA, immunoprecipitates of anti-NuMA
mAb were also analyzed by antibodies specific to other
domains of 4.1R. Analysis of anti-NuMA mAb immuno-
Figure 5. Subcellular localiza-
tion of 4.1R and NuMA pro-
teins. MDCK cells were frac-
tionated and 20 mg proteins
(unless mentioned otherwise)
from the cytoplasm (equivalent
to  z1.6  3  105 cells), nuclear
(equivalent to z5 3 105 cells),
and nuclear matrix (equivalent
to  z7 3 106 cells) fractions were
analyzed as described in Materi-
als and Methods. Shown are im-
munoblots of preimmune serum
for anti-HP 4.1 Ab (A), anti-HP
4.1 Ab (B), anti-24 kD Ab (C),
anti-10 kD Ab (D), anti-NuMA
Ab (E), anti–Na1-K1-ATPase
a1 Ab (F), antidynein mAb (G),
and anti–g-tubulin Ab (H). The
blot in I was immunoblotted
with antipericentrin Ab and was
loaded with 50 mg proteins from
each fraction.Mattagajasingh et al. Protein 4.1R Interacts with NuMA 37
precipitates by immunoblotting using anti-24 kD Ab (data
not shown because of the poor quality of the immunoblot)
revealed the presence of the 135-kD 4.1R isoform that was
detected by using anti-HP 4.1 Ab, but did not show the
presence of other isoforms of 4.1R. These data further
support our contention that a 135-kD isoform(s) of 4.1R
interacts with NuMA, although it does not eliminate the
possibility that other isoforms of 4.1R or 4.1-like genes
also interact with NuMA. Because actin, spectrin, and
calmodulin were reported to interact with 4.1R, immuno-
precipitates of anti-HP 4.1 Ab and anti-NuMA mAb were
also analyzed by Western blot using antibodies specific to
these proteins. However, actin (Fig. 7 C), spectrin (Fig. 7
D), or calmodulin (data not shown) was not detected
in the immunoprecipitates of anti-HP 4.1 Ab and anti-
NuMA mAb.
4.1R Associates with Mitotic Spindle Pole Organizing 
Proteins such as NuMA, Dynein, and Dynactin
To test whether 4.1R might also reside in association with
other components of the mitotic apparatus, we asked
whether it could be found in association with other pro-
teins that are known to organize the mitotic spindle and
spindle poles. Increasing evidence from different laborato-
ries suggests that NuMA, dynein, and dynactin form a
complex that organizes the spindle pole and stabilizes the
mitotic spindle (Merdes et al., 1996; Gaglio et al., 1997;
Heald et al., 1997). Therefore, we enriched cells with mi-
totic spindle and spindle pole organizing components by
using double thymidine block and nocodazole. After-
wards, we performed immunoprecipitation in highly syn-
chronized mitotic HeLa extracts using anti-HP 4.1 Ab,
anti-NuMA mAb, antidynein (70.1) mAb, or antidynactin
(p150glued, the 150-kD component of the dynactin com-
plex) mAb. We looked for the presence of 4.1R, NuMA,
dynein, and dynactin in the immunoprecipitates by immu-
noblot. An irrelevant antibody (anti-p53 mAb) and mouse
IgG were used as controls for mAbs. To rule out nonspe-
cific aggregation as a basis for detecting proteins on immu-
noblots and in the immunoprecipitates, preimmune rabbit
serum was used as a control for Abs. 
As shown in Fig. 8 A, z140-kD protein, immunoprecip-
itated and detected by immunoblot staining using anti-HP
4.1 Ab (lane 1), coprecipitated with NuMA, dynein, and
dynactin (lanes 3, 5, and 6, respectively) when immunopre-
cipitation was performed with anti-NuMA mAb, antidy-
nein mAb or antidynactin mAb (p150glued), but not by pre-
immune serum, anti-p53 mAb, or mouse IgG (lanes 2, 4,
and 7, respectively). This z140 kD protein corresponds to
a 135-kD 4.1R isoform. We previously have documented
such an alteration in the mobility of 135-kD isoforms of
4.1R because of phosphorylation at mitosis (Huang, S.C.,
S.N. Mattagajasingh, and E.J. Benz, Jr. 1997. Blood. 90:
269a). When these blots were stripped and reprobed with
antibodies specific for the COOH-terminal 24-kD domain
of 4.1R (Fig. 8 B, anti-24 kD Ab), the z140-kD protein
was seen in the immunoprecipitates of anti-HP 4.1, anti-
NuMA mAb, antidynein mAb, and antidynactin mAb
(lanes 1, 3, 5, and 6, respectively). No other convincing
protein band corresponding to other 4.1R isoforms was
seen in the immunoprecipitates (data not shown). Thus,
other isoforms of 4.1R are unlikely to associate with
NuMA, dynein, or dynactin.
When a replica of the blot in Fig. 8 A was probed with
anti-NuMA mAb (Fig. 8 C), an z230-kD band corre-
sponding to NuMA was seen in the immunoprecipitates of
anti-HP 4.1 Ab, anti-NuMA mAb, antidynein mAb, and
antidynactin (p150glued) mAb (lanes 1, 3, 5, and 6, respec-
tively), but not in any of the control antibodies (lanes 2, 4,
and 7). Similar analysis with appropriate antibodies de-
tected dynein (Fig. 8 D) and dynactin (Fig. 8 E) in immu-
noprecipitates of anti-HP 4.1 Ab, anti-NuMA mAb, anti-
dynein mAb, and antidynactin (p150glued) mAb (lanes 1, 3,
5, and 6, respectively), but not in any of the control anti-
bodies used for immunoprecipitation (lanes 2, 4, and 7).
These results suggest that 4.1R, NuMA, dynein, and dy-
nactin associate together in vivo, and nonspecific aggrega-
tion is unlikely to account for this association.
We attempted to quantitate how much 4.1R associates
with NuMA and vice versa, by analyzing the efficiencies of
their immunoprecipitation and coprecipitation. Represen-
tative immunoblots of anti-HP 4.1 Ab and anti-NuMA
mAb immunoprecipitated, along with the supernatant
fractions probed with anti-HP 4.1 Ab and anti-NuMA
Figure 6. Subcellular colocalization of protein 4.1 and NuMA at
various cell cycle stages of MDCK cells. MDCK cells were fixed
and processed for immunofluorescence with protein 4.1R and
NuMA antibodies as described in Materials and Methods. Shown
are cells in interphase (A1–A3), mitotic (B1–B3 and C1–C3), and
late mitotic stages (D1–D3). Green represents anti-HP 4.1
epitopes, red represents anti-NuMA epitopes, and yellow indi-
cates the colocalization of protein 4.1R and NuMA.The Journal of Cell Biology, Volume 145, 1999 38
mAb, are shown in Fig. 8, F and G, respectively. Quantita-
tion of the efficiencies of immunoprecipitation and copre-
cipitation from these blots showed that z39% of total cel-
lular 135-kD 4.1R protein was immunoprecipitated by
anti-HP 4.1 Ab which in turn brought down 11% of total
cellular NuMA. Similarly, z31% of NuMA protein was
immunoprecipitated by anti-NuMA mAb that brought
down z10% of 4.1R. It appears that under these condi-
tions about one-third of NuMA and 4.1R remain associ-
ated and antibodies, not the antigens, are the limiting fac-
tors.
To document the presence of other candidate proteins
in this protein complex, anti-HP 4.1 Ab immunoprecipi-
tates were examined by gel electrophoresis and silver
staining (Fig. 8 H). Approximately 15 prominent protein
bands of very high molecular mass (z40 kD) could be
seen on the gel. Protein bands that correspond to NuMA,
the p150glued subunit of the dynactin complex, 135-kD
4.1R, and dynein in immunoblots were seen on the gel and
are indicated in Fig. 8 H. To obtain an estimate of the mo-
lar ratios between NuMA, 4.1R, dynein, and dynactin in
the immunoprecipitated protein complex, we determined
the relative amounts of these proteins by scanning a pic-
ture of the silver stained gel of anti-HP 4.1 Ab immuno-
precipitates. The molar ratio between NuMA, 4.1R, and
dynactin was found to be 1:1.3:1.4. The molar ratio of the
dynein intermediate chain could not be determined be-
cause of higher background staining. However, different
proteins may not stain equally by silver stain (Sammons et al.,
1981). To examine the possible participation of other pro-
teins in this protein complex, known to bind to 4.1R such
as actin, spectrin, and calmodulin, we analyzed the anti-
HP 4.1 Ab and anti-NuMA mAb immunoprecipitates by
immunoblot staining using antibodies specific for these
proteins (data not shown). Neither actin, spectrin, nor
calmodulin was detected in these immunoprecipitates. The
identities of other proteins remain to be identified.
Our results extend the previous findings by Merdes et al.
(1996) and Gaglio et al. (1997). Merdes et al. (1996) pre-
sented persuasive evidence of dynein and dynactin in a mi-
totic spindle complex with NuMA. Gaglio et al. (1997)
also showed that microinjection of dynein-specific anti-
body blocked spindle formation by inhibiting the associa-
tion of dynein with the mitotic spindle and dislocating
NuMA from spindle poles. Our findings are consistent
with these observations and suggest that 4.1R, at least a
135-kD isoform, also participates in this complex. Results
obtained with control antibodies, coupled with the nonde-
tection of actin, spectrin, and calmodulin, support the con-
tention that our coimmunoprecipitation results are far
more likely to reflect a specific association in vivo rather
than a nonspecific aggregation artifact of the immunopre-
cipitation assays.
Overexpression of 13511kD/GFP Alters the 
Localization of NuMA
Because the above results suggested that there may be a
direct interaction between NuMA and 4.1R, and NuMA is
a nuclear protein, and is known to play a role in the orga-
nization of mitotic spindle and spindle poles, we asked if
overexpression of 4.1R could disturb the intracellular dis-
tribution of NuMA or disrupt the organization of mitotic
spindle and spindle poles. We transiently transfected
HeLa cells with 13511kD/GFP construct and examined
the effect of overexpression of this isoform on transfected
cells. Different degrees of 13511kD/GFP expression were
observed in transfected cells 10 h after transfection. In
most of the transfected cells, 13511kD/GFP fusion pro-
teins were located in the cytoplasm. However, in some
Figure 7. Coimmunoprecipitation of 4.1R and
NuMA from MDCK cell nuclear extracts.
MDCK nuclear extracts were prepared as de-
scribed in Materials and Methods and were sub-
jected to immunoprecipitation using different
antibodies. The immunoprecipitates were ana-
lyzed by immunoblotting using anti-HP 4.1 Ab
(A), anti-NuMA mAb (B), antiactin mAb (C),
or antispectrin mAb (D). In A and B, lanes 1–5
were loaded with one-fourth of the immunopre-
cipitates of anti-HP 4.1 Ab (lane 1), preimmune
serum (lane 2), anti-NuMA mAb (lane 3), anti-
p53 mAb (lane 4), and mouse IgG (lane 5).
Lanes 6 and 7 were loaded with one-ninth of the
supernatant fractions of anti-HP 4.1 Ab and anti-
NuMA mAb immunoprecipitates, respectively.
For C and D, lanes 1–5 were the same as in A,
and lane 6 was loaded with 40 mg of cell lysate.
Arrows indicate the position of actin in C and
that of a- and b-spectrin in D.Mattagajasingh et al. Protein 4.1R Interacts with NuMA 39
cells the fusion proteins could be detected in both cyto-
plasm and nucleus.
As shown in Fig. 9, GFP proteins were expressed in both
nuclei and cytoplasm of pEGFP-C1 vector transfected
HeLa cells (A1), whereas NuMA was exclusively localized
in the nuclei (A2). This suggests that the expression of
GFP protein alone did not alter the localization of NuMA
in the interphase nuclei. In contrast, nearly all of the
cells that strongly expressed 13511kD/GFP, regardless of
whether the localization of 13511kD/GFP was in the nu-
cleus or cytoplasm, showed altered localization of NuMA
in the interphase cells. NuMA was distributed diffusely in
these cells (Fig. 9, B2 and C2). The dispersed localization
of NuMA was not apparent in the cells that weakly ex-
pressed the fusion protein, as shown in the top cell of Fig.
9 B2. In the cells that expressed the GFP alone, the local-
ization of NuMA appeared to be defined by a boundary.
In cells that highly expressed the 13511kD/GFP fusion
protein, NuMA was diffusely distributed well beyond this
boundary. As shown in Fig. 9, B3 and C3, there was an en-
hancement of yellow in the cytoplasm due to a combina-
tion of green and red, indicating the colocalization of these
two proteins. This possibly suggests the appearance of
4.1R and NuMA complex aggregates in the cytoplasm,
Figure 8. Immunoprecipitaion from mitotic HeLa extracts
reveals that 4.1R associates with NuMA, cytoplasmic dy-
nein, and dynactin. Mitotic HeLa nuclear extracts were
prepared as described in Materials and Methods, and were
subjected to immunoprecipitation using different antibod-
ies. The immunoprecipitates were analyzed by immuno-
blotting using anti-HP 4.1 Ab (A and F), anti-24 kD Ab
(B), anti-NuMA mAb C and G, antidynein mAb (D), or
anti-p150glued mAb (E). In A–C, lanes 1–7 were loaded
with one fourth of the immunoprecipitates of anti-HP 4.1
Ab (lane 1), preimmune serum (lane 2), anti-NuMA mAb
(lane 3), anti-p53 mAb (lane 4), antidynein mAb (lane 5),
antidynactin mAb (lane 6), and mouse IgG (lane 7), re-
spectively. Lane 8 was loaded with 40 mg of mitotic HeLa
lysate. The anti-24 kD Ab recognized the 135-kD 4.1R iso-
form in the immunoprecipitates and is indicated by an ar-
row. The blot in D was probed with antidynein mAb and
lanes 1–7 were the same as A. The blot shown in E is the
same as C except that it was stripped and reprobed with
antidynactin mAb. Lanes 1–4 of the blot in F were loaded
with one-fourth of the immunoprecipitates of anti-HP 4.1
Ab (lane 1), preimmune serum (lane 2), anti-NuMA mAb
(lane 3), and mouse IgG (lane 4), respectively. Lanes 5 and
6 were loaded with one-ninth of the supernatant fractions
of anti-HP 4.1 Ab and anti-NuMA mAb immunoprecipi-
tates, respectively. The blot shown in (G) is the same as in
(F) except that it was stripped and reprobed with anti-
NuMA mAb. H is a silver-stained gel of molecular mass
markers (lane 1), immunoprecipitates of preimmune se-
rum (lane 2), and anti-HP 4.1 Ab (lane 3). The migration
position of 4.1R (135-kD isoform), NuMA, dynein, and dy-
nactin are indicated in the figure. Shown in I is the align-
ment of NuMA residues essential for its binding to 4.1R in
human and Xenopus (available in GenBank/EMBL/DDBJ
under accession number Y07624). The identical residues
shared by the two proteins are shaded and the conserved
amino acid changes are boxed. Numbers represent the po-
sition of respective amino acids. The peptide segment of
NuMA that interacts with 4.1R is highly conserved across
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where it is not found normally. Conversely, there was a
loss of staining signal in the nucleus in Fig. 9 B2 as com-
pared with nuclear staining of NuMA in vector/nontrans-
fected cells. 
These results suggest that overexpression of 13511kD
4.1R isoform in HeLa cells may disrupt the organization of
nuclear structural proteins such as NuMA. Cells that
strongly expressed 13511kD/GFP also gradually disap-
peared from the population 3–4 d after transfection. Fur-
thermore, the selected disappearance of cells that ex-
pressed the fusion protein raised the possibility that such
disruption of the normal organization of NuMA could ad-
versely affect the cell cycle progression since the majority
of 13511kD/GFP overexpressed cells were eliminated
from the cell population. It is interesting to note that
we have not been able to identify cells that strongly over-
express the 13511kD/GFP fusion protein in mitosis,
whereas cells that expressed the fusion protein very
weakly have been detected in mitosis. This preliminary ob-
servation is consistent with the notion that overabundance
of 13511kD 4.1R could indeed disrupt mitosis.
Discussion
Previous studies, from our laboratory and others (Tang
et al., 1990; Conboy et al., 1991), have documented the ex-
istence of multiple isoforms of 4.1R. Many of these iso-
forms are present in nonerythroid cells; their function and
biological significance remain unknown. In this study, we
demonstrate an interaction between a 135-kD noneryth-
roid isoform of 4.1R and NuMA by using a yeast two-
hybrid system, in vitro binding assays, coimmunoprecipi-
tation, and immunocolocalization studies. We also show
that a 135-kD 4.1R isoform resides in association with mi-
totic spindle pole organizing proteins such as NuMA, cyto-
plasmic dynein, and dynactin. Furthermore, overexpres-
sion of a 135-kD isoform alters the normal distribution of
NuMA in interphase cells that gradually disappear from
the cell population. Taken together, our results suggest
that a 135-kD 4.1R isoform interacts with NuMA in the
nucleus and nuclear matrix of interphase cells and in the
mitotic spindle and spindle poles of dividing cells.
While the results in this paper strongly indicate that one
or more isoforms of protein 4.1R interact with NuMA,
they do not precisely pinpoint any one of the many poten-
tial forms that can be generated by alternative splicing of
the 4.1R pre-mRNA. We believe that the isoforms of 4.1R
that interact with NuMA are in the 135-kD molecular
mass class even though NuMA interacts with both the 135-
kD and 80-kD 4.1R isoforms in both yeast two-hybrid as-
says and in vitro binding assays. Indeed, NuMA does not
even interact directly with HP that distinguishes the two
molecular mass classes. These findings are compatible be-
cause the artificially created proximity between binding
sites on each molecule in in vitro assays can allow them to
interact, even if compartmentalization of the molecules,
their proximity, orientation, posttranslational modifica-
tion, or the presence of modifying factors precluded their
interaction in intact cells. Further studies with additional
domain specific antibodies and RT-PCR methods will be
needed to define the exact isoform(s) that interact(s) in
vivo.
Our studies are the first that specifically implicate pro-
tein 4.1R, as opposed to other members of the protein 4.1
family (4.1G, 4.1N, 4.1B), as a likely participant in mitosis.
Previous studies from our group (Marchesi, V.T., S.
Huang, T.K. Tang, and E.J. Benz, Jr. 1990. Blood. 76:12a)
and from other laboratories have reported similar localiza-
tion and redistribution of 4.1 in a cell cycle–dependent
manner. Krauss et al. (1997a,b) reported the presence of
4.1 in centrosomes. Additionally, using double label elec-
tron microscopy, they have shown the colocalization of
epitopes for 4.1 and the centrosome-specific autoimmune
serum, 5051. Lallena and Correas (1997) also reported the
localization of 4.1R in the nucleus. However, a recent
study (Walensky et al., 1998) showed that epitopes for an-
tibodies used in the above studies could be found among
other protein 4.1 family members. In this present study,
antibodies specific to HP, which is unique to 4.1R, were
used. Therefore, our results strongly suggest that 4.1R iso-
form(s) containing HP localize(s) in the nucleus, centri-
oles, spindle fibers, and other intranuclear structures.
Differential localization of isoforms of other cytoskele-
tal proteins has been reported. For example, isoforms of
band 3 with different 59 ends localize either to peripheral
membranes or to perinuclear regions (Cox et al., 1995).
b-Spectrin isoforms with different COOH termini also ex-
hibit different subcellular localization and binding part-
Figure 9. Alteration in the localization of NuMA in 13511kD/
GFP 4.1R-transfected HeLa cells. HeLa cells transfected with
pEGFP or 13511kD/GFP were fixed and processed for immuno-
fluorescence with NuMA antibody and visualized for the local-
ization of GFP (green) and NuMA (red). Shown are cells trans-
fected with pEGFP (A1–A3) or 13511kD/GFP (B1–B3 and
C1–C3). Green represents fluorescence of GFP, red represents
anti-NuMA epitopes, and yellow indicates the colocalization of
GFP and NuMA.Mattagajasingh et al. Protein 4.1R Interacts with NuMA 41
ners (Malchiodi-Albedi et al., 1993). Since the localization
and redistribution of 4.1R during cell division that we have
described here are similar to that of NuMA (Price and
Pettijohn, 1986), these are consistent with its interaction
with NuMA, and imply a novel location and role for a cy-
toskeletal protein.
NuMA is well known for its role in the formation and
stabilization of the mitotic spindle (Kallajoki et al., 1991;
Compton et al., 1992; Yang and Snyder, 1992; Gaglio et al.,
1995). Accumulation of NuMA has been shown at the mi-
totic spindle poles and at or near the minus ends of micro-
tubules (Kallajoki et al., 1991; Yang and Snyder, 1992;
Maekawa and Kuriyama, 1993; Tang et al., 1993; Dionne
et al., 1999). Sequestration of endogenous NuMA by mi-
croinjection of anti-NuMA antibodies into mitotic cultured
cells was shown to disrupt the bipolar mitotic spindles
(Kallajoki et al., 1991; Yang and Snyder, 1992; Gaglio et
al., 1995). The spindle association activity of NuMA was
mapped to its COOH-terminal part (residues 1538–2115;
Tang et al., 1994). A recent study showed that the critical
sequences for spindle pole localization are contained within
the amino acid residues 1750–1800 of NuMA (Gueth-Hallo-
net et al., 1996). However, the mechanism by which NuMA
binds to microtubules is not clear. NuMA does not contain
a microtubule-binding region of kinesin (Yang et al., 1989),
Map2 (Lewis et al., 1988), or tau (Himmler et al., 1989),
but has been shown to directly bind to tubulin and orga-
nize microtubule formation through the distal portion of
its COOH-terminal domain (Merdes et al., 1996).
Because 4.1R does not contain a microtubule-binding
motif, it is possible that the localization of 4.1R at the mi-
totic spindle and spindle poles occurs through its interac-
tion with NuMA or other proteins that directly bind to mi-
crotubules. Two other proteins, dynein and dynactin, with
whom NuMA has been shown to form a complex at mito-
sis (Merdes et al., 1996), also possess microtubule binding
domains (Waterman-Storer et al., 1995; Gee et al., 1997)
and have been shown to organize and stabilize mitotic
spindle and spindle poles (Gaglio et al., 1996, 1997). In a
recent study, microinjection of dynein-specific antibodies
into intact cells or immunodepletion of dynein from mi-
totic extracts disturbed assembly of mitotic spindle or mi-
totic aster, respectively, and prevented accumulation of
NuMA at the spindle poles (Gaglio et al., 1997), suggest-
ing that the accumulation of NuMA at the spindle poles
may be dynein-dependent. However, the precise mecha-
nism of organization of the microtubules or the localiza-
tion of NuMA at the polar ends of the mitotic spindle is
not clear.
Several lines of evidence support individual roles for
NuMA, dynein, and dynactin. In an immunodepletion ex-
periment using frog extracts, Merdes et al. (1996) ob-
served a complex between NuMA, cytoplasmic dynein,
and dynactin; the depleted extract failed to assemble nor-
mal mitotic spindles. Although this observation suggests
that the complex between NuMA, cytoplasmic dynein,
and dynactin may have a role in the assembly and stabili-
zation of mitotic spindle, NuMA was found to associate
with microtubules independent of cytoplasmic dynein
(Gaglio et al., 1996). Additionally, organization of micro-
tubules to astral arrays and association of NuMA and dy-
nactin with the microtubules of the astral arrays have been
observed in mitotic HeLa extracts from which cytoplasmic
dynein (a minus end–directed motor protein) and Eg5 (a
plus end–directed motor protein) were depleted. This sug-
gests that NuMA may be associated with a second minus
end–directed motor protein yet to be defined (Gaglio et al.,
1996). This view is further supported by the observation
that NuMA accumulated at spindle ends in the absence of
dynein activity and that inhibition of NuMA blocked the
movement of microtubule seeds on spindle arrays (Heald
et al., 1997). Because NuMA has the ability to form fila-
mentous networks, it has also been suggested that it may
be mechanistically involved in the organization of micro-
tubules of the mitotic spindle (Saredi et al., 1996) and/or
serve to counterbalance the forces exerted against the mi-
crotubules by the putative motor to which it is attached
(Gaglio et al., 1996).
The focus of the present study was to gain clues about
the function of the novel 135-kD nonerythroid isoform of
4.1R by identifying its binding partners. We did not detect
the presence of actin, spectrin, or calmodulin in the immu-
noprecipitates of nuclear or mitotic extracts, although
these proteins are known to bind to 4.1R (Becker et al.,
1990; Tanaka et al., 1991; Morris and Lux, 1995) in eryth-
rocytes. It is possible that in association with 4.1R iso-
forms, these proteins serve different functions. Their asso-
ciation with nuclear 4.1 isoform(s), like the 135-kD 4.1R,
has not been documented. Nevertheless, it appears that a
nuclear isoform of 4.1R interacts with NuMA in the inter-
phase nucleus. It is not yet known if 4.1R and NuMA
remain associated throughout the cell cycle or if their as-
sociation is dynamic. The biological significance of this in-
teraction is also not known at this time. However, the data
shown in Fig. 9 suggest that perturbations of protein 4.1R
alter the localization of NuMA. Cells that overexpress the
135-kD 4.1R isoform perished within a time frame of three
to four cell divisions. Even though our data do not define a
particular role for 4.1R, it is tempting to speculate that
4.1R might stabilize the interaction among NuMA, dynein,
dynactin, and microtubules, in a manner analogous to its
role in stabilizing the association of spectrin, actin, and in-
tegral membrane proteins in red cells. This is further sup-
ported by the demonstration that 4.1 epitopes are local-
ized in nuclei, and asters and mitotic spindles. Moreover,
the fact that antibodies specific for 4.1 perturb the forma-
tion of these structures in the Xenopus system (Krauss,
S.W., R. Heald, G. Lee, T. Berger, and J.A. Chasis. 1998.
Mol. Biol. Cell. [Suppl.] 9:294a) lends additional support.
However, more attempts to modify mitosis or in vitro re-
construction of astral arrays, by altering 4.1R expression
or supply, will be required to test this notion.
The binding sites between 4.1R and NuMA have been
mapped to the amino acids encoded by exons 20 and 21 of
the COOH-terminal domain of 4.1R and to amino acids
1788–1810 of NuMA (Fig. 3). Because these residues of
4.1R are highly conserved among a growing 4.1R-like gene
family (Walensky et al., 1998) it is possible that the
polypeptide interacting with NuMA is a member of the
4.1R-like gene family. However, as discussed earlier, our
results strongly implicate a 135-kD isoform of protein
4.1R. Of the three alternative COOH termini of NuMA
that have been detected (Tang et al., 1993), amino acid
residues 1788–1810 of NuMA, which are necessary for itsThe Journal of Cell Biology, Volume 145, 1999 42
interaction with 4.1R, are located within an alternatively
spliced exon that is also known to code for the COOH ter-
minus required for its nuclear localization and spindle as-
sociation. A comparison of human and frog amino acid
residues of NuMA (Fig. 8 I) in the region required for its
interaction with 4.1R shows that this sequence is highly
conserved (95%), although the proteins have only 48%
overall homology (Merdes et al., 1996). The especially
strong conservation of the interacting sequences of NuMA
and 4.1R (Huang et al., 1993) could reflect an important
role in a fundamental cell process, such as cell division.
Thus, it appears that the isoform of NuMA that localizes
to the nucleus and associates with spindle also binds with
4.1R, and further supports our earlier contention that 4.1R
is present in the nucleus (Marchesi, V.T., S. Huang, T.K.
Tang, and E.J. Benz, Jr. 1990. Blood. 76:12a).
The precise role played by 4.1R in spindle assembly is
not known at present. However, our data strongly suggest
that 4.1R is involved in some fashion. A role for 4.1R in
cell division is supported by data that meet the same crite-
ria used to document the initial involvement of NuMA,
dynein, and dynactin in this process. Since 4.1R forms a
complex with all these proteins, and can alter the localiza-
tion of NuMA when perturbed, our data suggest that 4.1R
may also be crucial for the organization of the mitotic
spindle. Further work will be needed to establish the steps
in these processes for which protein 4.1R is important.
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